abstract |
The present disclosure provides methods and pharmaceutical compositions for treating or slowing the progression of cancer, ie, pancreatic or esophageal cancer, by administering to a human subject in need thereof a therapeutically effective amount of an inhibitor of the histone methyltransferase SETD2. |